QIMR Berghofer-led research in collaboration with Australian oncology company Kazia Therapeutics has found that combining the drug candidate paxalisib with immunotherapy triggered a molecular ...

As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds ...

Jessie J has shared the experience of having her "worst day so far," during her ongoing health crisis concerning breast cancer.

However, more long-term research is needed. Radiation therapy is a type of breast cancer treatment that uses high intensity energy beams to destroy cancer cells. Almost 65% of people who receive a ...

In this study, we designed a cell-penetrating gold nanoparticle platform to increase drug delivery to brain metastatic breast cancer cells. TAT peptide-modified gold nanoparticles carrying doxorubicin ...

To assess the performance of the suggested model, the outcomes of this study (Modified ResNet 18) are compared with ResNet 18 and ResNet 50. Modified ResNet 18 exhibits the highest accuracy of 97%, ...

According to doctors, the biggest triggers of breast cancer are a combination of factors, which include genetic predisposition, lifestyle choices, and environmental exposures. Risk factors like age, ...

More attention has been paid to immunotherapy for ovarian cancer and the development of tumor vaccines. We developed a trichostatin A (TSA)-modified tumor vaccine with potent immunomodulating ...

Breast cancer is the most common cancer in women in the United States, except for skin cancers. It accounts for about 30% (or 1 in 3) of all new female cancers each year. The American Cancer Society's ...

A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't seen major drug advances in over a decade, researchers reported Monday.

Breast cancer that is suddenly diagnosed without pain or noticeable symptoms. Breast cancer, which is the most common cancer ...